CRP and breast carcinoma: Thereinto, a meta-analysis published in 2009 found that a natural log (ln) unit increase in CRP was not statistically significant associated with breast cancer risk (relative risk [RR] = 1.10, 95% confidence interval [CI]: 0.97–1.26).